Johnson & Johnson (JNJ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2023
Revenue
Total Revenue	97.9B	94.2B	88.8B	85.2B	80.0B
Cost of Revenue	28.9B	25.6B	27.5B	26.6B	24.6B
Gross Profit	69.0B	68.6B	61.4B	58.6B	55.4B
Operating Expenses
R&D Expense	15.1B	14.7B	17.2B	15.1B	14.1B
SG&A Expense	25.1B	23.7B	22.0B	20.1B	20.2B
General & Admin Expense	5.9B	23.7B	22.0B	20.1B	20.2B
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	2.5B	4.6B	—	—	—
Total Operating Expenses	42.7B	43.0B	39.2B	35.2B	34.4B
Cost and Expenses	71.7B	68.6B	66.7B	61.8B	59.0B
Operating Income (EBIT)	26.3B	25.6B	22.1B	23.4B	21.0B
Non-Operating
Interest Income	912.0M	1.1B	1.3B	1.3B	490.0M
Interest Expense	1.0B	971.0M	755.0M	772.0M	276.0M
Net Interest Income	(100.0M)	85.0M	577.0M	489.0M	214.0M
Other Non-Op Income/Expense	(1.1B)	7.0B	(5.5B)	(8.3B)	(1.7B)
Non-Operating Income (excl Interest)	275.0M	(8.0B)	4.7B	7.6B	1.4B
EBT (Pre-Tax Income)	25.2B	32.6B	16.7B	15.1B	19.4B
Income Tax Expense	4.2B	5.8B	2.6B	1.7B	3.0B
Bottom Line
Net Income	21.0B	26.8B	14.1B	35.2B	17.9B
Earnings from Cont. Ops	21.0B	26.8B	14.1B	13.3B	16.4B
Earnings from Discont. Ops	—	—	—	21.8B	1.6B
Bottom Line Net Income	21.0B	26.8B	14.1B	35.2B	17.9B
Per Share
Basic EPS	$8.65	$11.03	$5.84	$13.88	$6.83
Diluted EPS	$8.63	$11.03	$5.79	$13.72	$6.73
Revenue Per Share	$40.13	$38.78	$36.90	$33.61	$30.61
Shares
Basic Shares Outstanding	2.4B	2.4B	2.4B	2.5B	2.6B
Diluted Shares Outstanding	2.4B	2.4B	2.4B	2.6B	2.7B
Profitability Metrics
EBITDA	33.7B	41.1B	24.8B	23.3B	26.6B
D&A	7.8B	7.5B	7.3B	7.5B	7.0B
EBIT	26.0B	33.6B	17.4B	15.8B	19.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026